- Potential benefitStabilizes Medicare payment rates for certain DME suppliers through the end of 2025.
- Potential benefitReduces the likelihood of sudden revenue drops for suppliers previously in the 2021 bidding round.
- Potential benefitHelps maintain beneficiary access to durable medical equipment by supporting supplier participation.
DMEPOS Relief Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
This bill (DMEPOS Relief Act of 2025) directs the HHS Secretary to apply the transition rule in 42 C.F.R. §414.210(g)(9)(v) to applicable durable medical equipment items formerly in the 2021 DMEPOS competitive bidding round for areas other than rural or noncontiguous areas through December 31, 2025. It also prohibits implementation of 42 C.F.R. §414.210(g)(9)(vi) until January 1, 2026, and authorizes the Secretary to implement these provisions by program instruction or other means.
Liberals stress beneficiary access and supplier stability
Relative to its intended legislative type, this bill is a narrowly targeted substantive policy change that clearly directs the Secretary of HHS to apply and defer specified regulatory provisions governing Medicare DMEPOS payments, with clear dates and authority for implementation via program instruction.
This bill (DMEPOS Relief Act of 2025) directs the HHS Secretary to apply the transition rule in 42 C.F.R. §414.210(g)(9)(v) to applicable durable medical equipment items formerly in the 2021 DMEPOS competitive bidding round for areas other than rural or noncontiguous areas through December 31, 2025.
It also prohibits implementation of 42 C.F.R. §414.210(g)(9)(vi) until January 1, 2026, and authorizes the Secretary to implement these provisions by program instruction or other means.
Technocratic, time-limited Medicare payment adjustment has modest chances—likely to succeed if bundled into a larger legislative vehicle; standalone passage less certain.
Relative to its intended legislative type, this bill is a narrowly targeted substantive policy change that clearly directs the Secretary of HHS to apply and defer specified regulatory provisions governing Medicare DMEPOS payments, with clear dates and authority for implementation via program instruction. It integrates explicitly with existing regulatory text but omits fiscal acknowledgment, reporting, and contingency language.
Liberals stress beneficiary access and supplier stability
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenLikely increases Medicare outlays compared with immediate implementation of lower competitive-bid rates.
- Potential burdenCreates unequal treatment between areas by applying the transition for some locations only.
- Potential burdenMay delay market incentives for price competition and efficiency among DME providers.
Why the argument around this bill splits.
Liberals stress beneficiary access and supplier stability
Likely supportive as a near-term protection for beneficiaries and small suppliers facing payment cuts from competitive bidding changes.
Would view the bill as a pragmatic pause to prevent service disruptions while seeking longer-term solutions that preserve access.
Generally supportive of a temporary, administrative pause to avoid provider disruption, but seeks cost estimates and clarity.
Would favor tying the pause to data and ensuring the pause is narrowly tailored and time-limited.
Skeptical because it delays implementation of competitive bidding rules that aim to reduce Medicare spending.
Some conservatives might accept a brief administrative delay to avoid immediate disruptions, but many will oppose undermining market-based rate-setting.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic, time-limited Medicare payment adjustment has modest chances—likely to succeed if bundled into a larger legislative vehicle; standalone passage less certain.
- No cost estimate or Congressional Budget Office score included
- Degree of supplier/provider support or opposition unknown
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals stress beneficiary access and supplier stability
Technocratic, time-limited Medicare payment adjustment has modest chances—likely to succeed if bundled into a larger legislative vehicle; s…
Relative to its intended legislative type, this bill is a narrowly targeted substantive policy change that clearly directs the Secretary of HHS to apply and defer specified regulatory provisions governing Medicare DMEPO…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.